BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 1928079)

  • 1. Pediatric uses of recombinant human erythropoietin: the outlook in 1991.
    Alexander SR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):42-53. PubMed ID: 1928079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of recombinant human erythropoietin (rHuEpo) in humans.
    Adamson JW; Eschbach JW
    Cancer Surv; 1990; 9(1):157-67. PubMed ID: 2276112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin associated hypertension among pediatric dialysis patients.
    Komatsu Y; Ito K
    Adv Perit Dial; 1992; 8():448-52. PubMed ID: 1361845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human recombinant erythropoietin therapy].
    Donato H; Ferro H
    Medicina (B Aires); 2006; 66(1):51-69. PubMed ID: 16555732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of recombinant human erythropoietin therapy on renal transplantation.
    Ettenger RB; Marik J; Grimm P
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):57-61. PubMed ID: 1928081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of long-term erythropoietin therapy in chronic hemodialysis patients with renal anemia].
    Ohkubo M; Ishimitsu T; Kawaguchi T; Abe M; Yagi S
    Nihon Jinzo Gakkai Shi; 1993 Feb; 35(2):171-7. PubMed ID: 8315880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of erythropoietin on blood pressure.
    Raine AE; Roger SD
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):76-83. PubMed ID: 1928084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Personal experience with the use of human recombinant erythropoietin in the treatment of anemia in children with chronic renal insufficiency].
    Podracká L; Sasinka M; Roland R; Böör A
    Cesk Pediatr; 1992 May; 47(5):268-71. PubMed ID: 1638649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term effects of recombinant human erythropoietin on the cardiovascular system.
    Eschbach JW; Aquiling T; Haley NR; Fan MH; Blagg CR
    Clin Nephrol; 1992; 38 Suppl 1():S98-103. PubMed ID: 1295715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
    Henry DH; Abels RI
    Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report.
    Adamson W; Egrie JC; Browne JK; Downing MR; Eschbach W
    Behring Inst Mitt; 1988 Aug; (83):188-92. PubMed ID: 3071336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologic basis for the pharmacologic use of recombinant human erythropoietin in surgery and cancer treatment.
    Adamson JW; Spivak JL
    Surgery; 1994 Jan; 115(1):7-15. PubMed ID: 8284765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once weekly subcutaneous administration of recombinant erythropoietin in children treated with CAPD.
    Goldraich I; Goldraich N
    Adv Perit Dial; 1992; 8():440-3. PubMed ID: 1361843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the alpha adrenergic system and increase in blood pressure with recombinant human erythropoietin (rHuEpo) therapy for renal anemia.
    Müller R; Steffen HM; Brunner R; Saric J; Pollok M; Baldamus CA; Kaufmann W
    Clin Invest Med; 1991 Dec; 14(6):614-22. PubMed ID: 1665406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin use in peritoneal dialysis patients.
    Zimmerman SW; Johnson CA
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):38-41. PubMed ID: 1928078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of human recombinant erythropoietin (rHuEPO) for treatment of anemia in patients with chronic kidney failure who don't require additional dialysis therapy].
    Wiecek A
    Przegl Lek; 1995; 52(3):93-4. PubMed ID: 7644683
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant human erythropoietin in a patient with multiple myeloma and end-stage renal disease.
    Holley JL; Nolan TA; Piraino B
    Clin Nephrol; 1992 Mar; 37(3):145-7. PubMed ID: 1563119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study of recombinant human erythropoietin treatment in pre-dialysis end stage renal disease patients.
    Yamazaki C; Watanabe Y; Sakamoto N
    Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1233-42. PubMed ID: 8139135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of renal anemia.
    Peco-Antic A
    Turk J Pediatr; 2005; 47 Suppl():19-27. PubMed ID: 15884663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of low-dose erythropoietin in predialysis chronic renal failure patients.
    Mitwalli A; Abuaisha H; al Wakeel J; al Mohaya S; Alam AA; el Gamal H; Fayed H
    Nephrol Dial Transplant; 1993; 8(10):1085-8. PubMed ID: 8272220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.